<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the management of gallstones</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the management of gallstones</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the management of gallstones</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Salam F Zakko, MD, FACP, AGAF</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nezam H Afdhal, MD, FRCPI</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sanjiv Chopra, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The presence of gallstones in the gallbladder (cholelithiasis) is common, particularly in Western populations. In the United States, gallstones are seen in approximately 6 percent of men and 9 percent of women [<a href="#rid1">1</a>]. Most individuals with gallstones are asymptomatic throughout their life and gallstones are found incidentally. The approach to the management of patients with gallstones depends upon the patient's symptoms, imaging test findings, and whether complications are present. </p><p>This topic will review the approach to the patient with uncomplicated gallstones. The discussion that follows is generally consistent with <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F349%2Fbmj.g6241%3Fetoc%3D&amp;token=cQPYGFzowbrgeI4ozEoovnnkAcMfzyOZR3N24vVpT%2Fxwiljmt2WhuABtAO3Yfj3u%2BRevY6kfZ51PatID1GvnMA%3D%3D&amp;TOPIC_ID=673" target="_blank">guidelines</a> from the National Institute for Health and Care Excellence [<a href="#rid2">2</a>]. Separate topic reviews on gallstone disease and its complications include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/662.html" rel="external">"Gallstones: Epidemiology, risk factors and prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults"</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3684.html" rel="external">"Treatment of acute calculous cholecystitis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/672.html" rel="external">"Acalculous cholecystitis: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/658.html" rel="external">"Acute cholangitis: Clinical manifestations, diagnosis, and management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/656.html" rel="external">"Mirizzi syndrome"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3683.html" rel="external">"Gallstone ileus"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5652.html" rel="external">"Clinical manifestations and diagnosis of acute pancreatitis"</a>.)</p><p></p><p class="headingAnchor" id="H1266582525"><span class="h1">TERMINOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gallstone disease</strong> – The term gallstone disease refers to gallstones that cause symptoms.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uncomplicated gallstone disease</strong> – The term uncomplicated gallstone disease refers to stones in the gallbladder that are associated with biliary colic in the absence of complications. (See  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults", section on 'Complications'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complicated gallstone disease </strong>– The term "complicated gallstone disease" refers to gallstone complications (eg, acute cholecystitis, cholangitis, gallstone pancreatitis, gallstone ileus, and Mirizzi syndrome). </p><p></p><p class="headingAnchor" id="H2538227688"><span class="h1">UNCOMPLICATED GALLSTONE DISEASE</span></p><p class="headingAnchor" id="H4222226277"><span class="h2">Biliary colic</span></p><p class="headingAnchor" id="H1620410415"><span class="h3">Acute pain management</span><span class="headingEndMark"> — </span>During an acute attack of biliary colic, management is focused on pain control. Pain control can usually be achieved with nonsteroidal anti-inflammatory drugs (NSAIDs) [<a href="#rid3">3</a>]. We reserve opioids (eg, <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a>, <a class="drug drug_general" data-topicid="8538" href="/d/drug information/8538.html" rel="external">hydromorphone</a>, <a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">meperidine</a>) for patients who have contraindications to NSAIDs or who do not achieve adequate pain relief with NSAIDs. </p><p>We use <a class="drug drug_general" data-topicid="8591" href="/d/drug information/8591.html" rel="external">ketorolac</a> for patients who present to the emergency department with biliary colic. Treatment usually relieves symptoms within 10 to 30 minutes. Patients are then prescribed oral NSAIDs (eg, <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>) for subsequent attacks that may occur while the patient is awaiting cholecystectomy. Patients who are managed as outpatients should be instructed to report to the emergency department if the pain does not resolve within four hours of the start of the pain because they are then at risk for developing complications such as acute cholecystitis. (See  <a class="medical medical_review" href="/d/html/3684.html" rel="external">"Treatment of acute calculous cholecystitis", section on 'Pain control'</a> and <a class="local">'Elective cholecystectomy'</a> below.)</p><p>The role of NSAIDs in the treatment of biliary colic was demonstrated in a meta-analysis of 11 randomized trials with 1076 patients that compared NSAIDs with no treatment, placebo, or other treatments [<a href="#rid3">3</a>]. The NSAIDs studied included <a class="drug drug_general" data-topicid="8591" href="/d/drug information/8591.html" rel="external">ketorolac</a>, <a class="drug drug_general" data-topicid="9348" href="/d/drug information/9348.html" rel="external">diclofenac</a>, <a class="drug drug_general" data-topicid="110865" href="/d/drug information/110865.html" rel="external">tenoxicam</a>, <a class="drug drug_general" data-topicid="8470" href="/d/drug information/8470.html" rel="external">flurbiprofen</a>, and <a class="drug drug_general" data-topicid="8590" href="/d/drug information/8590.html" rel="external">ketoprofen</a>. NSAIDs were more likely to control pain than placebo (relative risk [RR] 3.8; 95% confidence interval [CI] 1.7-8.6) or antispasmodics (RR 1.5; 95% CI 1.0-2.1). There was no difference in pain control between NSAIDs and opioids (RR 1.1; 95% CI 0.8-1.3). NSAIDs may also favorably alter the natural history of biliary colic, possibly due to the role of prostaglandins in the development of acute cholecystitis [<a href="#rid4">4,5</a>]. (See  <a class="medical medical_review" href="/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis", section on 'Epidemiology'</a>.)</p><p>It was traditionally thought that <a class="drug drug_general" data-topicid="9608" href="/d/drug information/9608.html" rel="external">meperidine</a> is the narcotic of choice in patients with biliary colic or gallstone pancreatitis because it has less of an effect on sphincter of Oddi motility than <a class="drug drug_general" data-topicid="9788" href="/d/drug information/9788.html" rel="external">morphine</a> [<a href="#rid6">6-8</a>]. However, all opioids result in increased sphincter of Oddi pressure [<a href="#rid7">7</a>]. There are insufficient data to suggest that morphine should be avoided. Morphine has an advantage that it requires less frequent dosing than meperidine, which has a shorter half-life. (See  <a class="medical medical_review" href="/d/html/3684.html" rel="external">"Treatment of acute calculous cholecystitis", section on 'Pain control'</a>.)</p><p class="headingAnchor" id="H430237008"><span class="h3">Subsequent management</span></p><p class="headingAnchor" id="H3347959734"><span class="h4">Elective cholecystectomy</span><span class="headingEndMark"> — </span>For patients with typical biliary colic and gallstones on imaging who are surgical candidates, we recommend elective cholecystectomy in order to prevent future attacks of biliary colic and complications of gallstone disease  (<a class="graphic graphic_algorithm graphicRef104170" href="/d/graphic/104170.html" rel="external">algorithm 1</a>). For those patients whose biliary colic subsides while in the emergency department, follow-up for elective cholecystectomy should be arranged as emergency cholecystectomy is associated with a higher risk of complications [<a href="#rid9">9</a>]. </p><p>We refer patients for cholecystectomy after an isolated attack of biliary colic even though approximately a third of patients with a first episode of biliary colic will not develop a recurrence within two years [<a href="#rid10">10</a>]. The rationale for our approach is that some patients may have unrecognized recurrent attacks if the initial attacks were not severe enough to have prompted medical attention.</p><p>Cholecystectomy is typically performed laparoscopically, though it may also be performed through an open right upper quadrant incision. Compared with open cholecystectomy, laparoscopic cholecystectomy reduces postoperative pain and significantly shortens hospital length of stay and convalescence, and time away from work, and is preferred by many patients from a cosmetic viewpoint. However, the laparoscopic procedure has been associated with an increased risk of common bile duct injury. In addition, the laparoscopic procedure may require conversion to an open procedure due to a variety of technical or patient issues. (See  <a class="medical medical_review" href="/d/html/3681.html" rel="external">"Complications of laparoscopic cholecystectomy"</a>.)</p><p>Major complications of cholecystectomies include bleeding, abscess formation, bile leak, biliary injury, and bowel injury. Approximately 5 to 12 percent of patients develop diarrhea, mostly in response to a large load of ingested fat in the diet, though in many cases the diarrhea will improve or resolve over weeks to months. Cholecystectomy has also been associated with an increased risk for right-sided colon cancer, esophageal cancer, and small intestinal cancer. This may be related to the effects of increased concentrations of the bile acid deoxycholic acid in the gut lumen as a result of loss of the gallbladder, which normally acts as a reservoir for concentrated bile acids. (See  <a class="medical medical_review" href="/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings", section on 'Post-cholecystectomy diarrhea'</a> and  <a class="medical medical_review" href="/d/html/2606.html" rel="external">"Epidemiology and risk factors for colorectal cancer", section on 'Cholecystectomy'</a>.)</p><p class="headingAnchor" id="H3208115479"><span class="h4">Alternatives to cholecystectomy</span><span class="headingEndMark"> — </span>Patients who are unable to undergo cholecystectomy are managed expectantly. For patients who have had an isolated episode of biliary colic without complications and prefer to avoid surgery, expectant management may be a reasonable alternative. However, it is important that patients who elect not to undergo cholecystectomy understand the risk of subsequent complications and are educated about the symptoms of biliary colic and instructed to seek medical attention if symptoms develop (see  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults", section on 'Natural history and disease course'</a>). In addition, patients should undergo evaluation of stone type, size, and gallbladder function to determine if they are candidates for oral dissolution therapy. (See  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults", section on 'Biliary colic'</a> and  <a class="medical medical_review" href="/d/html/670.html" rel="external">"Overview of nonsurgical management of gallbladder stones", section on 'Management'</a>.)</p><p class="headingAnchor" id="H1971698683"><span class="h2">Asymptomatic gallstones</span></p><p class="headingAnchor" id="H664441735"><span class="h3">Expectant management</span><span class="headingEndMark"> — </span>The majority of patients with asymptomatic (incidental) gallstones do not require treatment. Patients can usually be managed expectantly and referred for cholecystectomy if symptoms subsequently develop. </p><p>Prophylactic cholecystectomy is <strong>not</strong> indicated for most patients with asymptomatic gallstones since the risk of developing life-threatening, severe complications is low, and if symptoms do occur, they are generally mild initially. However, patients with asymptomatic gallstones must be educated about the symptoms of gallstone disease so they can seek treatment before more severe symptoms or complications develop. (See  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults", section on 'Symptomatic gallstones'</a> and  <a class="medical medical_review" href="/d/html/654.html" rel="external">"Overview of gallstone disease in adults", section on 'Complications'</a>.)</p><p>There are no prospective trials comparing surgical or medical therapy for asymptomatic gallstones. However, decision analysis models have shown no benefit with prophylactic cholecystectomy. In fact, one decision analysis demonstrated that prophylactic cholecystectomy slightly decreased survival and was not associated with an appreciable gain in discounted life-years gained [<a href="#rid11">11</a>]. Although the model was constructed prior to the development of laparoscopic cholecystectomy, it is unlikely that the laparoscopic approach would significantly alter the results based upon the results of the sensitivity analysis included in the study.</p><p class="headingAnchor" id="H1160252"><span class="h3">Cholecystectomy in selected patients</span></p><p class="bulletIndent1"><span class="glyph utd-adt-cnt utd-adt-pathwys">●</span><strong>Increased</strong> <strong>risk</strong> <strong>of</strong> <strong>gallbladder</strong> <strong>cancer</strong> – Cholecystectomy is indicated for patients at increased risk for gallbladder cancer, provided they are good surgical candidates. (See  <a class="medical medical_review" href="/d/html/2491.html" rel="external">"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis"</a>.) <span class="utd-adt-cnt utd-adt-pathwys utd-content-120418">(Related Pathway(s):  <a class="utd-content-120418" href="/pathway/120418?topicRef=673&amp;source=see_link">Gallstones: Management of an adult with gallstones (symptomatic or asymptomatic)</a>.)</span></p><p></p><p class="bulletIndent1">Patients at increased risk for gallbladder cancer include those with one of the following [<a href="#rid12">12,13</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Anomalous pancreatic ductal drainage (in which the pancreatic duct drains into the common bile duct) (see  <a class="medical medical_review" href="/d/html/651.html" rel="external">"Biliary cysts", section on 'Abnormal pancreatobiliary junction and cancer'</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Gallbladder adenomas (see  <a class="medical medical_review" href="/d/html/646.html" rel="external">"Gallbladder polyps"</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Porcelain gallbladder (see  <a class="medical medical_review" href="/d/html/643.html" rel="external">"Porcelain gallbladder"</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Large gallstones (particularly if larger than 3 cm) [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemolytic disorders</strong> – Patients with sickle cell disease and hereditary spherocytosis have a high incidence of forming pigment gallstones (50 percent or more) [<a href="#rid15">15,16</a>]. Because of this, we suggest cholecystectomy for patients with sickle cell disease if abdominal surgery is being performed for other reasons. In patients with hereditary spherocytosis, our approach is to perform a cholecystectomy if the patient has gallstones, and a splenectomy is being performed as part of the treatment for hereditary spherocytosis. (See  <a class="medical medical_review" href="/d/html/3589.html" rel="external">"Hepatic manifestations of sickle cell disease", section on 'Cholelithiasis'</a> and  <a class="medical medical_review" href="/d/html/7079.html" rel="external">"Hereditary spherocytosis", section on 'Management'</a>.)</p><p></p><p>Prophylactic cholecystectomy for asymptomatic gallstones is not indicated in patients with diabetes mellitus or those undergoing bypass surgery for obesity. Patients with diabetes mellitus may be at increased risk for the development of severe gangrenous cholecystitis [<a href="#rid17">17</a>]. However, the proportion of patients who develop biliary colic and other gallstone complications are similar to the general population [<a href="#rid18">18-20</a>]. Patients who have undergone gastric bypass surgery have a high incidence of developing gallstones (greater than 30 percent) [<a href="#rid21">21,22</a>]. However, cholecystectomy at the time of bypass in patients with asymptomatic gallstones is controversial. This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/662.html" rel="external">"Gallstones: Epidemiology, risk factors and prevention", section on 'Rapid weight loss'</a> and  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Cholelithiasis'</a>.)</p><p class="headingAnchor" id="H3509001910"><span class="h2">Atypical symptoms and gallstones</span></p><p class="headingAnchor" id="H76871339"><span class="h3">Evaluate for alternative etiologies</span><span class="headingEndMark"> — </span>In some patients, the atypical symptoms are related to the gallstones, but that in others they are due to another cause and the gallstones are an incidental finding. Patients with atypical symptoms in the absence of biliary colic should undergo evaluation for alternative etiologies  (<a class="graphic graphic_algorithm graphicRef104170" href="/d/graphic/104170.html" rel="external">algorithm 1</a>). It is also important to note that symptoms may change over time and patients with continued symptoms should be carefully reassessed, paying specific attention to the type of ongoing symptoms and if biliary colic has developed [<a href="#rid23">23</a>]. </p><p class="headingAnchor" id="H1793091564"><span class="h3">Trial of ursodiol and subsequent management</span><span class="headingEndMark"> — </span>In patients with no alternative explanation for atypical symptoms, we suggest an empiric trial of ursodiol for three months to identify patients who will benefit from cholecystectomy. Ursodiol relieves symptoms in many patients within a few weeks, even though gallstones are still present, possibly by changing the viscosity of bile. Dissolution of gallstones is slow and therapy may be required for two or more years. (See  <a class="medical medical_review" href="/d/html/670.html" rel="external">"Overview of nonsurgical management of gallbladder stones", section on 'Monitoring and duration'</a>.)</p><p>Cholecystectomy is a reasonable alternative if a thorough evaluation for other causes of the patient's symptoms is negative and if the patient has a symptomatic response to dissolution therapy, especially in patients who want to discontinue ursodiol therapy. However, patients should be informed that the response rates to cholecystectomy in patients with atypical symptoms and gallstones are lower than those seen for patients with typical biliary colic. In a systematic review of 23 studies looking at the effect of cholecystectomy for patients with gallstones, 92 percent of patients with biliary colic had symptom relief following cholecystectomy [<a href="#rid24">24</a>]. However for patients with upper abdominal pain, symptom relief rates after elective cholecystectomy ranged from 66 to 77 percent. Factors that predict a response to cholecystectomy were evaluated in a study of 1008 patients with upper abdominal pain and gallstones [<a href="#rid25">25</a>]. Upper abdominal pain relief was reported by 594 patients (59 percent) following cholecystectomy. Independent factors associated with pain relief following cholecystectomy included pain that occurred once a month or less, pain that began one year or less prior to surgery, and nocturnal awakening due to pain. Factors associated with a lower likelihood of achieving pain relief were the presence of lower abdominal pain, an abnormal bowel pattern, and associated bloating. (See  <a class="medical medical_review" href="/d/html/670.html" rel="external">"Overview of nonsurgical management of gallbladder stones"</a> and  <a class="medical medical_review" href="/d/html/19.html" rel="external">"Functional dyspepsia in adults", section on 'Management'</a>.)</p><p>Patients who fail to respond to ursodiol should instead be treated for disorders more consistent with their symptoms (eg, functional dyspepsia in a patient with bloating). (See  <a class="medical medical_review" href="/d/html/19.html" rel="external">"Functional dyspepsia in adults", section on 'Management'</a>.)</p><p class="headingAnchor" id="H4261463387"><span class="h1">COMPLICATED GALLSTONE DISEASE</span><span class="headingEndMark"> — </span>The complications of cholelithiasis include acute cholecystitis, choledocholithiasis, gallstone pancreatitis, acute cholangitis, gallstone ileus, Mirizzi syndrome, and gallbladder cancer. The management of these complications is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/3684.html" rel="external">"Treatment of acute calculous cholecystitis"</a> and  <a class="medical medical_review" href="/d/html/5633.html" rel="external">"Management of acute pancreatitis"</a> and  <a class="medical medical_review" href="/d/html/658.html" rel="external">"Acute cholangitis: Clinical manifestations, diagnosis, and management"</a> and  <a class="medical medical_review" href="/d/html/3683.html" rel="external">"Gallstone ileus", section on 'Treatment'</a> and  <a class="medical medical_review" href="/d/html/656.html" rel="external">"Mirizzi syndrome", section on 'Management'</a> and  <a class="medical medical_review" href="/d/html/15097.html" rel="external">"Surgical management of gallbladder cancer"</a> and  <a class="medical medical_review" href="/d/html/2525.html" rel="external">"Prognosis and adjuvant treatment for localized, resected gallbladder cancer"</a> and  <a class="medical medical_review" href="/d/html/2499.html" rel="external">"Treatment of advanced, unresectable gallbladder cancer"</a> and  <a class="medical medical_review" href="/d/html/13922.html" rel="external">"Choledocholithiasis: Clinical manifestations, diagnosis, and management", section on 'Initial diagnostic evaluation'</a>.)</p><p class="headingAnchor" id="H4265169721"><span class="h1">GALLSTONES IN PREGNANCY</span><span class="headingEndMark"> — </span>The approach to women with gallstones who are pregnant is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/15095.html" rel="external">"Gallstone diseases in pregnancy"</a>.)</p><p class="headingAnchor" id="H27544591"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/116318.html" rel="external">"Society guideline links: Gallstones"</a>.)</p><p class="headingAnchor" id="H81408208"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15434.html" rel="external">"Patient education: Gallstones (The Basics)"</a> and  <a class="medical medical_basics" href="/d/html/16271.html" rel="external">"Patient education: Choosing surgery to treat gallstones (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/4578.html" rel="external">"Patient education: Gallstones (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to management</strong> – Most individuals with gallstones are asymptomatic throughout their life and gallstones are found incidentally. The approach to the management of patients with gallstones depends upon the patient's symptoms, imaging test findings, and whether complications are present. Gallstone complications include acute cholecystitis, cholangitis, gallstone pancreatitis, gallstone ileus, and Mirizzi syndrome. In general, patients with sludge or microlithiasis are managed the same as patients with gallstones. The term uncomplicated gallstone disease refers to stones in the gallbladder that are associated with biliary colic in the absence of complications. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with biliary colic</strong> – For patients with typical biliary colic and gallstones on imaging, we recommend cholecystectomy rather than expectant management (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). Such patients are likely to have recurrent attacks and are at risk for complications. For patients who have had an isolated episode of biliary colic without complications and wish to avoid surgery, expectant management may be a reasonable alternative provided that the patient understands the risk of subsequent complications developing. It is important that patients who do not undergo cholecystectomy be educated about the symptoms of biliary colic and be instructed to seek medical attention if symptoms develop. Dissolution therapy is a reasonable alternative in patients who are not surgical candidates. (See <a class="local">'Biliary colic'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymptomatic patients with incidental gallstones</strong> – For patients with incidental gallstones, we recommend expectant management rather than performing prophylactic cholecystectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_3" rel="external">Grade 1C</a>). Waiting until a patient becomes symptomatic before performing cholecystectomy prevents unnecessary surgery since the majority of patients with incidental gallstones will never develop biliary colic. However, prophylactic cholecystectomy is indicated for patients who are at increased risk for gallbladder cancer. It may also have a role in the treatment of some patients with hemolytic disorders. (See <a class="local">'Expectant management'</a> above and <a class="local">'Cholecystectomy in selected patients'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with atypical symptoms</strong> – For patients with atypical symptoms and gallstones, we suggest additional evaluation rather than cholecystectomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Such patients should be thoroughly evaluated for non-gallstone-related causes of their symptoms. Cholecystectomy is a reasonable alternative if a thorough evaluation for other causes of the patient's symptoms is negative and if the patient has a symptomatic response to dissolution therapy. (See <a class="local">'Atypical symptoms and gallstones'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117:632.</a></li><li><a class="nounderline abstract_t">Warttig S, Ward S, Rogers G, Guideline Development Group. Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ 2014; 349:g6241.</a></li><li><a class="nounderline abstract_t">Colli A, Conte D, Valle SD, et al. Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic. Aliment Pharmacol Ther 2012; 35:1370.</a></li><li><a class="nounderline abstract_t">Henderson SO, Swadron S, Newton E. Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic. J Emerg Med 2002; 23:237.</a></li><li><a class="nounderline abstract_t">Akriviadis EA, Hatzigavriel M, Kapnias D, et al. Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study. Gastroenterology 1997; 113:225.</a></li><li><a class="nounderline abstract_t">Elta GH, Barnett JL. Meperidine need not be proscribed during sphincter of Oddi manometry. Gastrointest Endosc 1994; 40:7.</a></li><li><a class="nounderline abstract_t">Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am J Gastroenterol 2001; 96:1266.</a></li><li><a class="nounderline abstract_t">Thune A, Baker RA, Saccone GT, et al. Differing effects of pethidine and morphine on human sphincter of Oddi motility. Br J Surg 1990; 77:992.</a></li><li><a class="nounderline abstract_t">Dimou FM, Adhikari D, Mehta HB, Riall TS. Trends in Follow-Up of Patients Presenting to the Emergency Department with Symptomatic Cholelithiasis. J Am Coll Surg 2016; 222:377.</a></li><li><a class="nounderline abstract_t">Festi D, Sottili S, Colecchia A, et al. Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL). Hepatology 1999; 30:839.</a></li><li><a class="nounderline abstract_t">Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D. Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival. Ann Intern Med 1983; 99:199.</a></li><li><a class="nounderline abstract_t">Leitzmann MF, Rimm EB, Willett WC, et al. Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med 1999; 341:777.</a></li><li><a class="nounderline abstract_t">Leitzmann MF, Giovannucci EL, Rimm EB, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998; 128:417.</a></li><li><a class="nounderline abstract_t">Diehl AK. Gallstone size and the risk of gallbladder cancer. JAMA 1983; 250:2323.</a></li><li><a class="nounderline abstract_t">BATES GC, BROWN CH. Incidence of gallbladder disease in chronic hemolytic anemia (spherocytosis). Gastroenterology 1952; 21:104.</a></li><li><a class="nounderline abstract_t">Bond LR, Hatty SR, Horn ME, et al. Gall stones in sickle cell disease in the United Kingdom. Br Med J (Clin Res Ed) 1987; 295:234.</a></li><li><a class="nounderline abstract_t">Reiss R, Nudelman I, Gutman C, Deutsch AA. Changing trends in surgery for acute cholecystitis. World J Surg 1990; 14:567.</a></li><li class="breakAll">Capocaccia L, the GREPCO group. Clinical symptoms and gallstone disease: Lessons from a population study. In: Epidemiology and prevention of gallstone disease, Capocaccia L, Ricci G, Angelico F, Attili AF (Eds), Lancaster MTP Press, 1984. p.153.</li><li><a class="nounderline abstract_t">Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology 1987; 7:913.</a></li><li><a class="nounderline abstract_t">Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307:798.</a></li><li><a class="nounderline abstract_t">Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991; 86:1000.</a></li><li><a class="nounderline abstract_t">Wattchow DA, Hall JC, Whiting MJ, et al. Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity. Br Med J (Clin Res Ed) 1983; 286:763.</a></li><li><a class="nounderline abstract_t">Karmacharya A, Malla BR, Joshi HN, et al. The predictive value of pre-operative symptoms including upper gastrointestinal endoscopy before laparoscopic cholecystectomy for elective symptomatic cholecystolithiasis. Kathmandu Univ Med J (KUMJ) 2013; 11:300.</a></li><li><a class="nounderline abstract_t">Berger MY, Olde Hartman TC, Bohnen AM. Abdominal symptoms: do they disappear after cholecystectomy? Surg Endosc 2003; 17:1723.</a></li><li><a class="nounderline abstract_t">Thistle JL, Longstreth GF, Romero Y, et al. Factors that predict relief from upper abdominal pain after cholecystectomy. Clin Gastroenterol Hepatol 2011; 9:891.</a></li></ol></div><div id="topicVersionRevision">Topic 673 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10464139" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prevalence and ethnic differences in gallbladder disease in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25360037" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnosis and management of gallstone disease: summary of NICE guidance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22540869" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Meta-analysis: nonsteroidal anti-inflammatory drugs in biliary colic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12426013" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Comparison of intravenous ketorolac and meperidine in the treatment of biliary colic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9207282" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Treatment of biliary colic with diclofenac: a randomized, double-blind, placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8163140" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Meperidine need not be proscribed during sphincter of Oddi manometry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11316181" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2207591" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Differing effects of pethidine and morphine on human sphincter of Oddi motility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26837281" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Trends in Follow-Up of Patients Presenting to the Emergency Department with Symptomatic Cholelithiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10498631" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6881778" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prophylactic cholecystectomy or expectant management for silent gallstones. A decision analysis to assess survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10477775" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Recreational physical activity and the risk of cholecystectomy in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9499324" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The relation of physical activity to risk for symptomatic gallstone disease in men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6632129" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Gallstone size and the risk of gallbladder cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14926818" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Incidence of gallbladder disease in chronic hemolytic anemia (spherocytosis).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3115390" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Gall stones in sickle cell disease in the United Kingdom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2238655" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Changing trends in surgery for acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2238655" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Changing trends in surgery for acute cholecystitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3653855" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : A population study on the prevalence of gallstone disease: the Sirmione Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7110244" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The natural history of silent gallstones: the innocent gallstone is not a myth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1858735" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6402238" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Prevalence and treatment of gall stones after gastric bypass surgery for morbid obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24899324" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The predictive value of pre-operative symptoms including upper gastrointestinal endoscopy before laparoscopic cholecystectomy for elective symptomatic cholecystolithiasis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12802649" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Abdominal symptoms: do they disappear after cholecystectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21699805" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Factors that predict relief from upper abdominal pain after cholecystectomy.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
